|
Market Cap (3-Jul) $62,137,976 (840th) |
Close (30-Jun) $0.86 |
Volume (30-Jun) 64,140 |
Shortsold (19-Jun) 737,517 (0.45%) (320th) |
|
52w High $1.12 |
52w Low $0.285 |
P/E - |
EPS -0.06 |
PIQ released this announcement to the ASX on 1 August 2022, 7:46. The announcement is marked as price sensitive, and is 5 page(s) in length and 918.29kb in size.
You can view all announcements from PIQ and see how they appear on a price chart on the announcements page.
At the date of this announcement, PIQ was 0.000% short sold according to ASIC data. It was ranked the 654th most shorted stock on the ASX. It is now ranked as the 320th most shorted stock on the ASX with 0.451% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PIQ | |
|---|---|
| Sonic Healthcare USA signs licence for PromarkerD in the US | 10 May 2023, 11:41 |
| Trading Halt | 8 May 2023, 9:15 |
| World Endometriosis Congress - New diagnostic test showcased | 5 May 2023, 8:15 |
| Potential breakthrough blood test for endometriosis | 1 August 2022, 7:46 |
| June 2022 Quarterly Activities Report and Appendix 4C | 28 July 2022, 9:31 |
| European PromarkerD patents expanded beyond diabetes | 25 July 2022, 8:13 |
| Investor Presentation | 18 July 2022, 11:06 |
You must be logged in to post a reply.
Proteomics International Laboratories 